JORDANN DEACON: Open Payments
NPI 1942939392 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$918 in 43 payments from 14 companies in 2025. Trend: 2023 $1,206 · 2024 $2,665 · 2025 $918
Food & beverage: $918
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 9 | $263 |
| Amgen Inc. | 4 | $103 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $78 |
| GENZYME CORPORATION | 3 | $73 |
| ABBVIE INC. | 4 | $67 |
| E.R. Squibb & Sons, L.L.C. | 4 | $65 |
| Novartis Pharmaceuticals Corporation | 3 | $65 |
| Organon LLC | 5 | $44 |
| Janssen Biotech, Inc. | 2 | $43 |
| Galderma Laboratories, L.P. | 2 | $43 |
Products named: DUPIXENT, Otezla, ILUMYA, Sotyktu, TREMFYA, NEMLUVIO, COSENTYX, RINVOQ.
Industry payments across NC — which companies pay providers there.
